The ISPOR Research Presentation Podium and Poster Awards were established in 1998 to recognize the scientific merit of podium and poster presentations of the ISPOR Annual International Meetings, Annual European Congresses, Asia-Pacific and Latin America Conferences.

This year, the ISPOR judges evaluated podium presentations and nominated poster presentations. All podium presentations are considered for an award. Poster presentations in the top 10%, based on abstract review score, are considered and eligible for a poster presentation award. 
Evaluations of scientific merit were based upon the following criteria:

  • Background provides appropriate perspective / context for the subject
  • Objectives / research questions are clearly stated
  • Research design / methods / modeling is appropriate and transparent (scores on this will determine winners in case of ties)
  • Data sources and/or sampling procedures are clear and appropriate
  • Data analyses are appropriate
  • Research objectives are met/addressed
  • Implications of findings are discussed
  • Factual information is kept separate from interpretations or implications
  • Abstract is presented in an unbiased manner
  • Clarity of presentation


ISPOR Best Podium Research Presentation Awards


Best General Podium Presentations

Madeleine T. King

CN2: Cross-Country Comparison of Cancer-Specific Multi-Attribute Utility Instruments (MAUIs): Relative Weighting and Ranking of Health-Related Quality of Life (HRQL) Domains in Country-Specific Utility Algorithms

Matthew Taylor

MO4: Assessing the Appropriateness of Existing Model Adaptation Methods for Low- and Middle-Income Countries

Tun-Ying Hsu

IN4: The Public Health Impact and Cost-Effectiveness of School-Based Nine-Valent Human Papillomavirus Female Vaccination Compared With Bi-Valent and Quadrivalent Vaccination in Malaysia


Best New Investigator Podium Research Presentations

Hui Yee Yeo

IN3: How Much Do Malaysians Value Dengue Vaccine? Evaluating the Willingness to Pay (WTP) for Hypothetical Dengue Vaccine With Two-Part Model (TPM)

Jianwei Xuan

IN1: Impact of Sofosbuvir-Based Regimens for Chronic Hepatitis C Infection: A Work Productivity Model From Mainland China

Maki Ueyama

PR3: Drivers of High Drug Prices in Japan, A Preliminary Research


Best Student Podium Research Presentations

Bhavana Shree Magaji

IN2: Trends of Prescription Pattern in Pediatric Intensive Care Unit: An Observational Study

Monique Dabbous

HT1: International Comparison of HTA Decisions for Oncology Products

Bunchai Chongmelaxme

AD4: Incorporating Adherence in Cosst-Effectiveness Analyses of Interventions for Asthma Treatment: A Systematic Review

ISPOR Best Poster Research Presentation Awards


Best General Poster Research Presentations

Pinaki Ghosh

PRM35: Systematic Review and Quality Appraisal of Cost-Effectiveness Analyses of Pharmacological Treatment for Chronic Obstructive Pulmonary Disease

Mallik Greene

PMH28: Impact of Comorbid Substance Abuse on Healthcare Utilization and Costs in Patients With Bipolar I Disorder Treated With Atypical Antipsychotics

Christie Teigland

PMH4: Prevalence and Likelihood of Hospital Admission and Readmission in Patients With Serious Mental Illness


Best New Investigator Poster Research Presentations

Hae-Young Park

PMS5: Association Between Steriod Exposure and Osteoporotic Fracture in Korean Women: A Nested Case-Control Study Using a National Sample Cohort

Lan Gao

PCN37: Cost-Effectiveness Analysis of Lipegfilgrastim as Primary Prophylaxis in Women With Breat Caner in Australia--A Modeled Economic Evaluation

Naoto Nakagawa

PIN20: A Cost-Effectiveness Analysis of Neuraminidase Inhibitors for Influenza Virus Infection in Japan 


Best Student Poster Research Presentations

Yasuhiro Hagiwara

PCN65: The EQ-5D Index of Elderly Patients With HER2-Positive Breast Cancer: Results From the Randomized N-SAS BC 07 Trial for  Adjuvant Trastuzumab With and Without Chemotherapy

Jeongeun Lee

PRM36: Validation of Health Utilities Using the EQ-5D-3L in Cohort Studies of Stroke Rehabilitation Patients

Lylia Chachoua

PSY6: Orphan Drugs Versus Ultra-Orphan Drugs: Price Comparison in England